Sustainable Endotoxin Testing in China: Chromogenic Assay with Recombinant Cascade Reagents from Top Suppliers and Factory
Products Features
The Recombinant Cascade Reagent (RCR) represents a significant advancement in bacterial endotoxin testing, serving as a sustainable and highly specific recombinant alternative to traditional Limulus Amoebocyte Lysate (LAL). Its development aligns with modern ethical and regulatory expectations while maintaining robust analytical performance.
Sustainable & Animal-Free
Utilizes recombinant technology (Factor C, Factor B, and proclotting enzyme) to eliminate dependency on horseshoe crab blood, supporting conservation and animal welfare.
Enhanced Specificity
Not activated by (1→3)-β-D-glucans, eliminating false-positive results and improving accuracy in complex pharmaceutical matrices.
Regulatory Compliance
Supported by emerging pharmacopeial standards, such as the proposed USP <86> chapter, facilitating adoption in regulated environments.
Proven Performance
Demonstrated excellent sample compatibility and comparable results to traditional LAL-based methods across real-world pharmaceutical products.
Frequently Asked Questions
What is Recombinant Cascade Reagent (RCR)?
RCR is a sustainable and highly specific recombinant alternative to traditional Limulus Amoebocyte Lysate (LAL) used for bacterial endotoxin testing in the pharmaceutical industry.
How does RCR support animal welfare and sustainability?
By utilizing recombinant technology, RCR is produced entirely animal-free. This eliminates the dependency on horseshoe crab blood, supporting conservation efforts while maintaining a stable reagent supply.
Does RCR mirror the reaction mechanism of traditional LAL?
Yes, RCR comprises recombinant Factor C, Factor B, and proclotting enzyme, ensuring a reaction mechanism that closely mirrors native LAL and correlates highly with conventional methods.
How does RCR prevent false-positive results?
Unlike native LAL reagents, RCR is not activated by (1→3)-β-D-glucans, which are known to cause false-positives, thereby improving testing accuracy in complex samples.
Is RCR recognized by regulatory standards?
Yes, the adoption of RCR is supported by emerging pharmacopeial standards, including the proposed USP <86> chapter titled "Bacterial Endotoxins Test Using Recombinant Reagents."
Can RCR be used for real-world pharmaceutical products?
Yes, RCR has demonstrated excellent sample compatibility and produced results comparable to traditional LAL-based methods across a range of real-world pharmaceutical products.